GO
Loading...

Enter multiple symbols separated by commas

U.S. Business Day Street Signs

More

  • Greenberg: Intuitive Surgical needs to show stabilization

    Shares of Intuitive Surgical surged on better-than-expected Q4 guidance. CNBC's Herb Greenberg provides perspective.

  • Are stocks overvalued? Tuesday, 14 Jan 2014 | 2:07 PM ET
    Are stocks overvalued?

    Sandy Villere, Villere & Co., and Darren Schuringa, Yorkville Capital Management, share their top stock picks. Schuringa likes Energy Transfer.

  • Exelixis CEO: 30,000 men will die of prostate cancer this year

    Michael Morrissey, Exelixis president & CEO, provides insight on clinical research of prostate cancer and its cancer drug Cometriq.

  • FUBU founder on 'Shark Tank' success Tuesday, 14 Jan 2014 | 2:53 PM ET
    FUBU founder on 'Shark Tank' success

    "Shark Tank's" Daymond John discusses which participants are successful on "Shark Tank," and the current environment for selling some of these successful businesses.

  • Rising stars in social media Tuesday, 14 Jan 2014 | 2:41 PM ET
    Rising stars in social media

    CNBC's Julia Boorstin reports on 3 rising social startups, including "Jelly," which enables users to ask questions to their social network through pictures.

  • Bentley Continental GT V8 available in '14 Monday, 13 Jan 2014 | 2:54 PM ET
    Bentley Continental GT V8 on sale late 2014

    CNBC's Phil LeBeau speaks with Bentley Motors Chief Operating Officer Christophe Georges about the launch of the Continental GT V8.

  • HSN Inc. CEO: Customer trust a priority Monday, 13 Jan 2014 | 2:48 PM ET
    HSN CEO: Customer trust a priority

    What can retailers do to protect customers' data? HSN Inc. CEO Mindy Grossman discusses how her company has invested in data security.

  • HSN Inc. CEO: Mobile was 12% of entire business Monday, 13 Jan 2014 | 2:47 PM ET
    HSN CEO: Mobile was 12% of entire business

    HSN Inc. CEO Mindy Grossman says her company invested in mobile, and remained focused on proprietary product and value and the customer experience. "It's about generosity; what are you doing for your customer not just because you want to sell them something," she says.

  • Alexandria CEO: Real estate a long-term play Monday, 13 Jan 2014 | 2:38 PM ET
    Alexandria CEO: Real estate a long-term play

    Alexandria Real Estate Equities founder, chairman and CEO Joel Marcus discuss its firm's success, and how rising yields impact its dividend.

  • Alexandria CEO: Top tenants looking for more space Monday, 13 Jan 2014 | 2:36 PM ET
    Alexandria CEO: Top tenants looking for more space

    Alexandria Real Estate Equities founder, chairman and CEO Joel Marcus discuss real estate demand in the biotech industry.

  • Health care ripe for revolution? Monday, 13 Jan 2014 | 2:34 PM ET
    Health care ripe for revolution?

    CNBC's Brian Sullivan and Josh Lipton discuss venture capital investments in health care.

  • Perrigo CEO: Elan purchase lowers tax rate Monday, 13 Jan 2014 | 2:24 PM ET
    Perrigo CEO: Elan purchase lowers tax rate

    Perrigo CEO Joseph Papa discusses how its new headquarters in Ireland will impact its tax structure, and whether the company will add a dividend.

  • Perrigo CEO: Got to get our name out Monday, 13 Jan 2014 | 2:24 PM ET
    Perrigo CEO: Got to get our name out

    Perrigo CEO Joseph Papa provides insight on the current flu season, and how it plans on getting its name better known.

  • Biogen CEO: More products, company is focused Monday, 13 Jan 2014 | 2:15 PM ET
    Biogen CEO: More products, company is focused

    Biogen Idec CEO George Scangos discusses the busy year ahead for the company, including the EU launch of Tecfidera and when a dividend will be offered.

  • Roche now world leader in cancer treatment: Pro Friday, 10 Jan 2014 | 2:45 PM ET
    Roche now world leader in cancer treatment: Pro

    The outlook for biotech is "wonderful," explains Sam Isaly, Orbimed Advisors managing partner.

  • Agios's new approach to cancer Monday, 13 Jan 2014 | 11:00 AM ET
    Agios's new approach to cancer

    Agios CEO David Schenkein on a new approach to cancer, and the outlook for product approval, from the JPMorgan Health Care Conference in San Francisco.

  • Accuray CEO: History of innovation Monday, 13 Jan 2014 | 10:00 AM ET
    Accuray CEO: History of innovation

    Accuray CEO Joshua Levine talks to CNBC's Brian Sullivan about his company's history of innovation and how it deals with larger competitors.

  • Target: Data breach affected up to 110 million Friday, 10 Jan 2014 | 1:34 PM ET

    Target disclosed that a mass information breach involved data belonging to up to 70 million customers.

  • Nasty correction this summer: Pro Monday, 13 Jan 2014 | 2:03 PM ET
    Nasty correction this summer: Pro

    Discussing current market action and what it signals about economic growth, with James Paulsen, Wells Capital Management CIO, and Linda Duessel, Federated Investors.

  • Retailers not as transparent as used to be: Kniffen Friday, 10 Jan 2014 | 2:13 PM ET
    Retailers not as transparent as used to be: Kniffen

    Digging into the financials of various retailers, including Five Below and Sears, with Jan Kniffen, CEO of Worldwide Enterprises, and Herb Greenberg of TheStreet.com.

About Street Signs

  • "Street Signs" airs live 2-3pm ET, Monday-Friday from CNBC Global Headquarters. The show is must see TV for savvy investors looking to capitalize on opportunities beyond the headlines and the herd mentality. Brian Sullivan and Amanda Drury read the signs on Wall Street everyday for the under-the-radar stocks and market trends to make you money.